1. Yazawa K, Fujimori M, Amano J, Kano Y and Taniguchi S.: Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumors., Cancer Gene Therapy, 2000, 7(2): 269-74.
  2. Nakamura T, Sasaki T, Fujimori M, Yazawa K, Kano Y, Amano J, and Taniguchi S.: Cloned Cytosine Deaminase Gene Expression of Bifidobacterium longum and Application to Enzyme/Pro-drug Therapy of Hypoxic solid tumors., Biosci. Biotechnol. Biochem., 2002, 66(11): 2362-2366.
  3. Sasaki T, Fujimori M, Hamaji Y, Hama Y, Ito, K, Amano J, and Taniguchi S.: Genetically engineered Bidfidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats., Cancer Sci., 2006, 97: 649-57.
  4. Fujimori M.: Genetically Engineered Bifidobacterium as a Drug Delivery System for Systemic Therapy of Metastatic Breast Cancer Patienets., Breast Cancer, 2006, 13(1): 27-31
  5. Kimura N, Taniguchi S, Aoki K, and Baba T.: Selective Localization and Growth of Bifidobacterium bifidum in Mouse Tumors following Intravenous Administration. Cancer Research, 1980, 40: 2061-8.
  6. Hamaji Y, Fujimori M, Sasaki T, Matsuhashi H, Matsui-Seki K, Shimatani-Shibata Y, Kano Y, Amano Y and Taniguchi S.: Strong Enhancement of Recombinant Cytosine Deaminase Activity in Bifidobacterium longum for Tumor-Targeting Enzyme/Prodrug Therapy., Biosci. Biotechnol. Biochem., 2007, 71(4): 874-83
  7. Taniguchi S, Fujimori M, Sasaki T, Tsutsui H, Shimatani Y, Seki K and Amano J.: Targeting solid tumors with non-pathogenic obligate anaerobic bacteria., Cancer Sci., 2010, 101(9): 1925-1932